Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10058045HBVENSG00000164305.20protein_codingCASP3NoNo836P42574
TVIS10058044HBVENSG00000164305.20protein_codingCASP3NoNo836P42574
TVIS30008701HIVENSG00000164305.20protein_codingCASP3NoNo836P42574
TVIS30008702HIVENSG00000164305.20protein_codingCASP3NoNo836P42574
TVIS30061613HIVENSG00000164305.20protein_codingCASP3NoNo836P42574
TVIS30061614HIVENSG00000164305.20protein_codingCASP3NoNo836P42574
TVIS44019305HTLV-1ENSG00000164305.20protein_codingCASP3NoNo836P42574
TVIS44019306HTLV-1ENSG00000164305.20protein_codingCASP3NoNo836P42574
TVIS44004779HTLV-1ENSG00000164305.20protein_codingCASP3NoNo836P42574
TCGA Plot Options
Drug Information
GeneCASP3
DrugBank IDDB13048
Drug NamePAC-1
Target IDBE0001162
UniProt IDP42574
Regulation Typeactivator
PubMed IDs31943757; 19708658
CitationsHuan LC, Anh DT, Truong BX, Duc PH, Hai PT, Duc-Anh L, Huong LT, Park EJ, Lee HJ, Kang JS, Tran PT, Thanh Hai DT, Kim Oanh DT, Han SB, Nam NH: New Acetohydrazides Incorporating 2-Oxoindoline and 4-Oxoquinazoline: Synthesis and Evaluation of Cytotoxicity and Caspase Activation Activity. Chem Biodivers. 2020 Mar;17(3):e1900670. doi: 10.1002/cbdv.201900670. Epub 2020 Feb 4.@@Peterson QP, Hsu DC, Goode DR, Novotny CJ, Totten RK, Hergenrother PJ: Procaspase-3 activation as an anti-cancer strategy: structure-activity relationship of procaspase-activating compound 1 (PAC-1) and its cellular co-localization with caspase-3. J Med Chem. 2009 Sep 24;52(18):5721-31. doi: 10.1021/jm900722z.
GroupsInvestigational
Direct ClassificationN-piperazineacetamides
SMILESOC1=C(C=NNC(=O)CN2CCN(CC3=CC=CC=C3)CC2)C=CC=C1CC=C
Pathways
PharmGKB
ChEMBLCHEMBL591429